Transparency-reporting trends in Europe

Fig. 1. Getting past European privacy rules for HCP consent is the biggest challenge to transparency rules. Credit: IMS Health In the US, with the passage and implementation of the Physicians Sunshine Act, most activities involving reported aggregated spending by […]

Read More

Dissecting the speed-to-therapy question

There is a lively (to be diplomatic) debate going on among manufacturers, specialty pharmacies (SPs) and outsourced hub providers over how best to serve patients that need specialty pharma therapies. Most of the time, these drugs are distinguished from conventional […]

Read More